AHMC Healthcare Inc., and Alhambra Hospital Medical Center Engage MedAssets for Enhanced Pricing Capabilities to Improve Overall Financial Performance

ATLANTA, Oct. 2, 2014 (GLOBE NEWSWIRE) -- MedAssets (Nasdaq:MDAS) today announced that AHMC Healthcare Inc., and Alhambra Hospital and Medical Center has expanded its relationship with the company in pursuit of a rational and defensible pricing strategy. Plans call for a combination of the company's Patient Access Solutions, Contract and Episode Management Solutions and Charge, Pricing and Compliance Solutions to improve the accuracy of patient bill estimation and gain market intelligence to inform payor contract negotiations.

"As a fully integrated healthcare system, it is important that we remain focused on aligning our pricing strategy across our entire continuum of care," said Linda Marsh, senior executive vice president, AHMC Healthcare Inc., and Alhambra Hospital Medical Center. "Validating that prices not only cover costs, but are also defensible, transparent and competitive, is an ongoing healthcare challenge that promises to only increase as a business priority. The expertise and proprietary data analytics tools from MedAssets promise to deliver insights and best practices to inform our charge and contract decisions, and optimize our net revenue while creating better pricing transparency to the community we serve."

Organizations across the country are improving business capabilities related to patient billing estimation, payor contract modeling and chargemaster management. Over the past 12 months, MedAssets has seen a nearly 30 percent year-over year increase in the number of providers employing the company's proprietary revenue cycle analytics tools, benchmarking data, technology automation and consulting services in pursuit of a rational and defensible pricing strategy.

"Providers are facing increasing pressure to balance revenue optimization with the needs of market participants, from payors to patients, and defensible pricing is key to succeeding with this evolving economic value equation," said Amy Amick, president, Revenue Cycle Management, MedAssets. "The breadth of our revenue cycle management capabilities delivers a 360-degree view of pricing that aggregates costs, volume, peers and payors. Our powerful analysis is then complemented by enabling SaaS-based technologies designed to boost productivity and compliance to assure pricing supports our clients' margin achievement goals while staying within hospital policies."

Tracking Actual Cost, Competition and Contractual Considerations

Pricing of patient services has played a traditional role in the financial performance of any hospital, but continues to be pressured by a number of market forces. Americans are paying a growing proportion of their own healthcare bills, and providers are beginning to compete more on cost, increasing the need to defend pricing of services. Provisions of the Affordable Care Act require hospitals to publish a list of "standard charges" for items and services. At the same time, new payor methods to rein in costs, such as narrow networks, value-based payment models, and comparison tools of provider costs and quality, are further complicating how providers establish contract pricing during payor negotiations.

MedAssets offers the following analytics tools and services to help providers achieve a defensible, yet optimal pricing strategy across the revenue cycle:

  • CarePricer – Web-based payment estimating technology to increase up-front cash collections, improve patient satisfaction and reduce self-pay bad debt
  • Chargemaster Managementproprietary data to benchmark 100 percent of charges and perform comparative pricing
  • Comparative Rate Modeling – pricing consulting with a strategic review to improve bottom line and increase the defensibility of charges by taking into account comparative market pricing and payor reimbursement mix
  • Contract Modelinghelps providers negotiate more favorable contracts, identify payor trends and more accurately forecast revenue
  • Defensible Price Modeling – pricing consulting that examines the relationship of charges to supply and pharmacy costs and reviews the impact of price changes on net revenue

The company is hosting a webinar through HFMA on Thursday, Oct. 9 from 2:00-3:00 p.m. CDT, for providers interested in learning how to create and maintain a defensible pricing strategy. MedAssets Vice President of Revenue Cycle Advisory Solutions, William Davis, will share the key elements to consider when evaluating a strategic pricing approach, and will discuss best practices for connecting pricing transparency to various programs, including patient access, charge capture, physician preference items and more.

About AHMC Healthcare Inc., and Alhambra Hospital Medical Center

Formed in November 2004, AHMC & AHMC Healthcare currently consists of six comprehensive acute care facilities all located in the Greater San Gabriel Valley area. These hospitals include Alhambra Hospital Medical Center, Garfield Medical Center, Greater El Monte Community Hospital, Monterey Park Hospital, San Gabriel Valley Medical Center, and Whittier Hospital Medical Center. Since our inception in 2004, AHMC & AHMC Healthcare has grown to a total over 1000 beds with over 7,000 employees and over 3,000 physicians all committed to providing the highest quality, most compassionate care for our community. For more information, please visit http://www.ahmchealth.com.

About MedAssets

MedAssets (Nasdaq:MDAS) is a healthcare performance improvement company focused on helping providers realize financial and operational gains so that they can sustainably serve the needs of their community. More than 4,400 hospitals and 122,000 non-acute healthcare providers currently use the company's evidence-based solutions, best practice processes and analytics to help reduce the total cost of care, enhance operational efficiency, align clinical delivery, and improve revenue performance across the care continuum. For more information, please visit www.medassets.com.


CONTACT: Media Contact: Robin Wrinn 678.624.7420 rwrinn@medassets.com Investor Contact: Robert Borchert 678.248.8194 rborchert@medassets.com